aCentre d’Investigations Cliniques Plurithématique 1433, Université de Lorraine, INSERM 1116, CHRU de Nancy
bF-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists Network, Nancy
cINSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Early Determinants of the Child's Health and Development Team (ORCHAD), Paris
dDepartement of Nephrology, Centre Hospitalier Universitaire de Reims
eFrench Clinical Research Infrastructure Network, Investigation Network Initiative – Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT), Reims, France
Correspondence to Nicolas Girerd, Centre d’Investigation Clinique Pierre Drouin – INSERM – CHRU de Nancy, Institut lorrain du coeur et des vaisseaux Louis Mathieu, rue du Morvan, 54500 Vandoeuvre-Les-Nancy, Nancy, France. Tel: +33 383157496; fax: +33 383157324; e-mail: [email protected]
Abbreviations: cIMT, carotid intima–media thickness; CRP, C-reactive protein; FABP-4, fatty acid-binding protein-4; IGFBP-1, insulin-like growth factor binding protein-1; IGFBP-2, insulin-like growth factor binding protein-2; IOTF, International Obesity Task Force; MMP-2, matrix metalloproteinase-2; MMP-3, matrix metalloproteinase-3; MMP-9, matrix metalloproteinase-9; NHANES III, the Third National Health and Nutrition Examination Survey; VEGF-A, vascular endothelial growth factor A
Received 14 June, 2022
Revised 8 November, 2022
Accepted 9 November, 2022
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).
